Shockwave Research
Individualized radial extracorporeal shock wave therapy (rESWT) for
symptomatic calcific shoulder tendinopathy: a retrospective clinical study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718020/
“One-year success rate was estimated at 92% and 1-year recurrence rate was 7%.”
The effectiveness of extracorporeal shockwave therapy for frozen
shoulder in patients with diabetes: randomized control trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642889/
“The Shockwave group benefited from significantly increased pain reduction, reduced number of therapy sessions and thus the costs of treatment compared to the Ultrasound group.”
Effectiveness of radial extracorporeal shock-wave therapy versus
ultrasound-guided low-dose intra-articular steroid injection in improving
shoulder pain, function, and range of motion in diabetic patients with
shoulder adhesive capsulitis
https://pubmed.ncbi.nlm.nih.gov/32553435/
“Both groups demonstrated a significant reduction in pain severity, as well as improvement in ROM. However, significantly greater function and shoulder pain reduction were found in the rESWT group vs. the steroid group. Similar improvement in shoulder ROM was observed in both groups.”
Effect of extracorporeal shock-wave therapy for treating patients with
chronic rotator cuff tendonitis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585514/
“The results of all outcome measurements show [shockwave therapy] significantly decreased the intensity of shoulder pain associated with chronic rotator cuff tendonitis, and increased shoulder function at both 4 and 8 weeks after the treatment.”
Extracorporeal shockwaves therapy versus hyaluronic acid injection
for the treatment of painful non-calcific rotator cuff
tendinopathies: preliminary results
https://pubmed.ncbi.nlm.nih.gov/27070534/
“low molecular weight hyaluronic acid and shockwave therapy are both effective and safe in patients suffering from non-calcific rotator cuff tendinopathy until 3 months of follow-up.”